Insiders Scoop Up Shares of This Biotech IPO, Energy Giant, and More

Photo of Trey Thoelcke
By Trey Thoelcke Published

Quick Read

  • MapLight Therapeutics Inc.’s (NASDAQ: MPLT) initial public offering tempted some huge insider buying.

  • Kinder Morgan Inc. (NYSE: KMI), MSC Industrial Direct Co. Inc. (NYSE: MSM), and others also saw notable insider purchases in the past week.

  • Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.(Sponsor)

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Insiders Scoop Up Shares of This Biotech IPO, Energy Giant, and More

© JHVEPhoto / iStock Editorial via Getty Images

In the past week or so, beneficial owners took advantage of MapLight Therapeutics Inc.’s (NASDAQ: MPLT) initial public offering. Meanwhile, the executive board chair of Kinder Morgan Inc. (NYSE: KMI) boosted his stake, and an insider bought a big block of MSC Industrial Direct Co. Inc. (NYSE: MSM) shares after it released a better-than-expected earnings report.

While insider buying is typically slower when markets are near all-time highs and when earnings-reporting season is in full swing, it never seems to dry up altogether. These recent notable purchases attest to this. Let’s take a quick look at these notable transactions and others.

Is Insider Buying Important?

insider buying
frender / iStock via Getty Images

What does insider buying tell us?

A well-known adage reminds us that corporate insiders and 10% owners really only buy shares of a company because they believe the stock price will rise and they want to profit from it. Thus, insider buying can be an encouraging signal for potential investors. This is all the more so during times of uncertainty in the markets, and even when markets are near all-time highs.

With the third-quarter earnings-reporting season still underway, many insiders are prohibited from buying or selling shares. Below are some of the most notable insider purchases that were reported recently, starting with the largest and most prominent.

MapLight Therapeutics

  • Buyer(s): 10% owners Catalyst4 and Novo Holdings
  • Total shares: almost 6.4 million
  • Price per share: $17.00
  • Total cost: around $108.7 million

An initial public offering brought out these buyers. MapLight Therapeutics is a clinical-stage biopharmaceutical company engaged in the development of novel therapeutics for central nervous system disorders like schizophrenia and Alzheimer’s. The gross proceeds of the IPO totaled $296.3 million.

Thus far, shares have traded in a range of $15.00 to $20.86, and they were last seen changing hands for over a dollar less than the offering price.

Note that Catalyst4 is a nonprofit founded by Google co-founder Sergey Brin, and it acquired more than 5 million of the shares listed above. Meanwhile, Novo Holdings, which is affiliated with Novo Nordisk A/S (NYSE: NVO), sold shares of IO Biotech Inc. (NASDAQ: IOBT) this past summer.

Kinder Morgan

  • Buyer(s): Executive Chair Richard Kinder and another director
  • Total shares: over 1.0 million
  • Price per share: $25.80 to $26.28
  • Total cost: more than $25.9 million

Kinder purchased a million of these Kinder Morgan shares, his largest single purchase in the past year. He acquired more than 670,000 shares this past summer. His stake is now up to 246.2 million shares.

Shares of this Houston-based energy infrastructure giant have retreated more than 5% since the most recent earnings report. The stock was last seen just below the purchase price range above. Analysts have a consensus price target of $31.05, which signals 19.6% upside in the next 12 months. Of 21 analysts that follow the stock, 12 recommend buying shares. Jefferies initiated coverage with a Hold rating last month.

MSC Industrial Direct

  • Buyer(s): a director
  • Total shares: around 181,800
  • Price per share: $83.60 to $85.00
  • Total cost: over $15.4 million

MSC Industrial Direct posted better-than-expected quarterly results last month. Since then, the stock is marginally lower, but shares were last seen trading for more than the purchase price range above. The year-to-date gain is about the same as that of the S&P 500.

The $87.50 consensus price target is less than 3% higher than the current share price. On average, analysts have Hold-equivalent ratings on the shares. However, J.P. Morgan recently reiterated an Overweight rating.

Note that this buyer’s stake is up to more than 2.3 million shares, making him a beneficial owner.

And Other Insider Buying

howtogoto / iStock via Getty Images

These were not the only notable insider purchases of the past week or so. Here’s a quick look at some others.

Stock Buyer(s) Shares Price Cost
Viridian Therapeutics Inc. (NASDAQ: VRDN) a director over 454,500 $22.00 nearly $10.0 M
Clarivate PLC (NYSE: CLVT) directors under 2.2M $3.25 to $3.55 over $7.3 M
Vivani Medical Inc. (NASDAQ: VANI) a director over 3.7M $1.62 about $6.0 M
Amrize Ltd. (NYSE: AMRZ) CEO 110,000 $52.28 to $53.11 over $5.8 M
Wolfspeed Inc. (NYSE: WOLF) 10% owner about 194,300 $25.84 to $27.83 over $5.1 M
Neumora Therapeutics Inc. (NASDAQ: NMRA) a director over 1.9M $2.61 nearly $5.0 M
Everest Group Ltd. (NYSE: EG) two directors almost 14,500 $306.08 to $307.38 over $4.5 M
Booz Allen Hamilton Holding Corp. (NYSE: BAH) CEO 23,800 $84.24 to $85.02 over $2.0 M
Celestica Inc. (NYSE: CLS) a director 6,000 $339.27 to $342.64 over $2.0 M

Recently, some smaller insider buying was reported at Atlanta Braves, Blackstone, Caesars Entertainment, Cigna, Coca-Cola, Iridium Communications, Matador Resources, Norfolk Southern, Northern Trust, Sonoco Products, Terex, Verisk Analytics, WD-40, and Winnebago as well.

Insiders Are Scooping Up Shares of a Miner, a Driller, and a Biotech

 

Photo of Trey Thoelcke
About the Author Trey Thoelcke →

Trey has been an editor and author at 24/7 Wall St. for more than a decade, where he has published thousands of articles analyzing corporate earnings, dividend stocks, short interest, insider buying, private equity, and market trends. His comprehensive coverage spans the full spectrum of financial markets, from blue-chip stalwarts to emerging growth companies.

Beyond 24/7 Wall St., Trey has created and edited financial content for Benzinga and AOL's BloggingStocks, contributing additional hundreds of articles to the investment community. He previously oversaw the 24/7 Climate Insights site, managing editorial operations and content strategy, and currently oversees and creates content for My Investing News.

Trey's editorial expertise extends across multiple publishing environments. He served as production editor at Dearborn Financial Publishing and development editor at Kaplan, where he helped shape financial education materials. Earlier in his career, he worked as a writer-producer at SVE. His freelance editing portfolio includes work for prestigious clients such as Sage Publications, Rand McNally, the Institute for Supply Management, the American Library Association, Eggplant Literary Productions, and Spiegel.

Outside of financial journalism, Trey writes fiction and has been an active member of the writing community for years, overseeing a long-running critique group and moderating workshop sessions at regional conventions. He lives with his family in an old house in the Midwest.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

ON Vol: 12,768,560
+$6.26
+11.25%
$61.92
MPWR Vol: 815,150
+$91.01
+9.08%
$1,093.35
COIN Vol: 12,673,291
+$13.82
+8.60%
$174.61
SMCI Vol: 37,649,439
+$1.71
+8.12%
$22.77
STX Vol: 3,527,049
+$29.33
+8.09%
$391.76

Top Losing Stocks

CEG Vol: 6,205,728
-$19.36
6.48%
$279.25
MKC Vol: 12,085,620
-$3.28
6.11%
$50.44
CF Vol: 7,054,005
-$7.76
5.64%
$129.84
EOG Vol: 6,302,371
-$5.32
3.55%
$144.57
APA
APA Vol: 13,809,565
-$1.30
2.97%
$42.44